Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Page 1
Barriers and confidence among colorectal and prostate cancer survivors participating in two behavioral intervention studies.
Liu VN, Zuniga KB, Paciorek A, Zhang L, Chan JM, Carroll PR, Van Loon K, Laffan A, Venook A, Van Blarigan EL, Kenfield SA. Liu VN, et al. Among authors: paciorek a. Support Care Cancer. 2023 Jul 10;31(8):453. doi: 10.1007/s00520-023-07901-5. Support Care Cancer. 2023. PMID: 37428241
Tailoring lifestyle interventions to participants' individual barriers and confidence is needed to promote and sustain behavior change long-term....
Tailoring lifestyle interventions to participants' individual barriers and confidence is needed to promote and sustain behavior change long- …
Cost-effectiveness analysis of primary treatments for localised prostate cancer: A population-based Markov analysis using real-world evidence.
Weng X, Zhong L, Xiang P, Li Y, Paciorek A, Dong L, Broering J, Carroll PR, Sanda M, Wilson L. Weng X, et al. Among authors: paciorek a. Eur J Cancer Care (Engl). 2022 Nov;31(6):e13740. doi: 10.1111/ecc.13740. Epub 2022 Oct 14. Eur J Cancer Care (Engl). 2022. PMID: 36239065
Treatment costs included office visits, hospitalisation, procedures, medication and long-term care. Patients' surveyed HRQoL were mapped into utilities. Incremental cost-effectiveness ratios (ICERs) used cost per quality-adjusted life years (QALYs) and willingness-to-pay o …
Treatment costs included office visits, hospitalisation, procedures, medication and long-term care. Patients' surveyed HRQoL were map …
A Ten-Year Experience of Treating Chronic Myeloid Leukemia in Rural Rwanda: Outcomes and Insights for a Changing Landscape.
Morgan J, DeBoer RJ, Bigirimana JB, Nguyen C, Ruhangaza D, Paciorek A, Mugabo F, Villaverde C, Nsabimana N, Bihizimana P, Umwizerwa A, Lehmann LE, Shulman LN, Shyirambere C. Morgan J, et al. Among authors: paciorek a. JCO Glob Oncol. 2022 Jul;8:e2200131. doi: 10.1200/GO.22.00131. JCO Glob Oncol. 2022. PMID: 35839427 Free PMC article.
CONCLUSION: Coupling molecular diagnostics with affordable access to imatinib within a comprehensive cancer care delivery program is a successful long-term strategy to treat CML in resource-constrained settings. Our patients are younger and have higher rates of imatinib re …
CONCLUSION: Coupling molecular diagnostics with affordable access to imatinib within a comprehensive cancer care delivery program is a succe …
Clinicopathologic Characteristics and Impact of Oophorectomy for Ovarian Metastases from Colorectal Cancer.
Ursem C, Zhou M, Paciorek A, Atreya CE, Ko AH, Venook A, Zhang L, Van Loon K. Ursem C, et al. Among authors: paciorek a. Oncologist. 2020 Jul;25(7):564-571. doi: 10.1634/theoncologist.2019-0282. Epub 2020 Feb 7. Oncologist. 2020. PMID: 32031306 Free PMC article.
A subset of patients with ovarian metastasis from CRC have potential to become long-term survivors (>5 years)....
A subset of patients with ovarian metastasis from CRC have potential to become long-term survivors (>5 years)....
Longitudinal Comparison of Patient-Level Outcomes and Costs Across Prostate Cancer Treatments With Urinary Problems.
Tang J, Zhong L, Paoli C, Paciorek A, Carroll P, Wilson L. Tang J, et al. Among authors: paciorek a. Am J Mens Health. 2019 Mar-Apr;13(2):1557988319835326. doi: 10.1177/1557988319835326. Am J Mens Health. 2019. PMID: 30836832 Free PMC article.
This study evaluated direct costs of treating urinary problems after PCa treatments and determined predictors of long-term costs for urinary problems. Data from the Cancer of Prostate Strategic Urologic Research Endeavor registry was analyzed for this study. ...
This study evaluated direct costs of treating urinary problems after PCa treatments and determined predictors of long-term costs for …
Sirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and vessel response.
Levy EI, Hanel RA, Howington JU, Nemes B, Boulos AS, Tio FO, Paciorek AM, Amlani S, Kagan-Hallett KS, Fronckowiak MD, Guterman LR, Hopkins LN. Levy EI, et al. Among authors: paciorek am. J Neurosurg. 2004 Apr;100(4):688-94. doi: 10.3171/jns.2004.100.4.0688. J Neurosurg. 2004. PMID: 15070124
These findings indicate that sirolimus-coated devices may inhibit in-stent stenosis. Further studies with longer-term follow up are required to assess the restenosis rates of sirolimus-coated stents implanted in the intracranial vasculature....
These findings indicate that sirolimus-coated devices may inhibit in-stent stenosis. Further studies with longer-term follow up are r …